NNSR Nanosensors, Inc. (OTCBB: NNSR) Monday's market went up 7.14% to $0.015 per share, with a total of 1,656,828 shares traded.
The company announced that it has engaged a third-party contractor to manufacture units of a test version of its biosensor product that will be used for third party field testing. The Company expects to receive delivery of the product units and commence testing during the first quarter of 2007 in order to obtain feedback on the performance of the biosensor. The product is based on the Company's recently licensed nanoporous silicon-based biosensor technology to detect e-coli. Although the Company has not entered into testing agreements with third parties, the Company is seeking to enroll between six to ten users in its product testing program in order to subject the product design to simulated field conditions and to further assess the commercial viability of the current design. It is expected that the testing cycle will continue for a period of approximately three months and the Company intends to deploy the biosensors in a number of different testing conditions. After the testing period is complete, the Company intends to incorporate user feedback into the product design in order to improve product functionality, as may be appropriate.
Nanosensors, Inc., a development stage company, engages in the development, manufacture, and marketing of sensors and instruments in the United States. These sensors are designed to detect specified levels of targeted specific biological, chemical, and explosive agents in areas that are a risk in the post 9/11-era. The company's technology operates in the nano-scale of ten to the minus ninth meters and is sensitive to the presence of nano-scale size molecules of B-C-X agents using nano-scale surface structures to detect the presence of these molecules at nano concentrations. Nanosensors was co-founded by Ted Wong and Matthew Zuckerman. The company was incorporated in 2003 and is headquartered in Santa Clara, California.
News 
Market Data 
Discover 
